Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: Comparisons to four common chronic diseases

European Journal of Pediatrics

Volumn 171, Issue 3, 2012, Pages 485-492

  Varni, James W ^a,b   Globe, Denise R ^c   Gandra, Shravanthi R ^c   Harrison, David J ^c   Hooper, Michele ^c   Baumgartner, Scott ^c  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c AMGEN INC   (United States)

Author keywords

Healthrelated quality of life; Patient reported outcomes; Pediatrics; PedsQL; Plaque psoriasis

Indexed keywords

CYCLOSPORIN; ETANERCEPT; METHOTREXATE; PLACEBO; RETINOID DERIVATIVE;

ADOLESCENT; ARTHRITIS; ARTICLE; ASTHMA; CHILD; CHRONIC DISEASE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; EMOTIONAL DISORDER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PEDIATRIC QUALITY OF LIFE INVENTORY; PHOTOTHERAPY; PHYSICAL DISABILITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PSORIASIS VULGARIS; QUALITY OF LIFE; SCHOOL; SCHOOL CHILD; SELF REPORT; SOCIAL INTERACTION; STUDENT T TEST;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; ASTHMA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PSORIASIS; PSYCHOLOGICAL TESTS; QUALITY OF LIFE; SELF REPORT; SEVERITY OF ILLNESS INDEX;

EID: 84860301390     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-011-1587-2     Document Type: Article

References (32)

1. Bastiaansen D, Koot HM, Bongers IL, Varni JW, Verhulst FC (2004) Measuring quality of life in children referred for psychiatric problems: psychometric properties of the PedsQLtm 4.0 Generic Core Scales. Qual Life Res 13:489-495 (Pubitemid 38392277)
2. Bastiaansen D, Koot HM, Ferdinand RF, Verhulst FC (2004) Quality of life in children with psychiatric disorders: self, parent, and clinician report. J Am Acad Child Adolesc Psychiatry 43:221-230
3. Beattie PE, Lewis-Jones MS (2006) A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 155:145-151 (Pubitemid 43876407)
4. Clarke SA, Eiser C (2004) The measurement of health-related quality of life in pediatric clinical trials: a systematic review. Health Qual Life Outcomes 2(66):1-5
5. Cohen J (1988) Statistical power analysis for the behavioral sciences. Erlbaum, Hillsdale
6. de Jager MEA, van de Kerkhof PCM, de Jong EMGJ, Seyger MMB (2010) A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scores. Br J Dermatol 163:1099-1101
7. Dillman DA, Smyth JD, Christian LM (2009) Internet, mail and mixed-mode surveys: the tailored design method. Wiley, New York
8. FDA (2009) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Food and Drug Administration, U.S. Department of Health and Human Services, Rockville, M.D.
9. Fredriksson T, Pettersson U (1978) Severe psoriasis: oral therapy with a new retinoid. Dermatologica 157:238-244 (Pubitemid 8387357)
10. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ (2004) Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 51:704-708 (Pubitemid 39516879)
11. Heydendael VMR, de Borgie CAJM, Spuls PI, Bossuyt PMM, Bos JD, de Rie MA (2004) The burden of psoriasis is not determined by disease severity only. J Invest Dermatol Symp Proc 9:131-135 (Pubitemid 38457270)
12. Kimball AB, Jacobson C,Weiss S, Vreeland MG,Wu Y (2005) The psychosocial burden of psoriasis. Am J Clin Dermatol 6:383-392 (Pubitemid 43128290)
13. Krueger G, Koo J, LebwohlM,Menter A, Stern RS, Rolstad T (1998) The impact of psoriasis on quality of life. Arch Dermatol 137:280-284
14. Langley RG, Paller AS, Hebert AA, Creamer K, Weng HH, Jahreis A, Globe D, Patel V, Orlow SJ (2011) Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial. J Am Acad Dermatol 64:64-70
15. Lewis-Jones MS, Finlay AY (1995) The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 132:942-949
16. Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I, Hebert AA, Eichenfield LF, Patel V, Creamer K, Jahreis A (2008) Etanercept treatment for children and adolescents with plaque psoriasis. New Engl J Med 358:241-251
17. Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Med Care 27:S217-S233
18. Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin DM (1999) Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 41:401-407 (Pubitemid 29418506)
19. Revicki DA, Menter A, Feldman SR, Kimel M, Harnam N, Willian MK (2008) Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study. Health Qual Life Outcomes 6(75):1-8
20. Russo PA, Ilchef R, Cooper AJ (2004) Psychiatric morbidity in psoriasis: a review. Australasian J Dermatol 45:155-161
21. Sampogna F, Tabolli S, Soderfeldt B, Axtelius B, Aparo U, Abeni D (2006) Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol 154:844-849
22. Shikiar R, Willian MK, Okun MM, Thompson CS, Revicki DA (2006) The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes 4(17):1-12
23. Upton P, Lawford J, Eiser C (2008) Parent-child agreement across child health-related quality of life instruments: a review of the literature. Qual Life Res 17:895-913
24. Varni JW, Burwinkle TM, Jacobs JR, GottschalkM, Kaufman F, Jones KL (2003) The PedsQLtmin type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventorytm Generic Core Scales and type 1 Diabetes Module. Diabetes Care 26:631-637 (Pubitemid 36929319)
25. Varni JW, Burwinkle TM, Rapoff MA, Kamps JL, Olson N (2004) The PedsQLtm in pediatric asthma: reliability and validity of the Pediatric Quality of Life Inventorytm Generic Core Scales and Asthma Module. J Behav Med 27:297-318 (Pubitemid 39024007)
26. Varni JW, Burwinkle TM, Seid M, Skarr D (2003) The PedsQLtm 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 3:329-341 (Pubitemid 37527280)
27. Varni JW, Limbers CA, Burwinkle TM (2007) How young can children reliably and validly self-report their health-related quality of life? An analysis of 8,591 children across age subgroups with the PedsQLtm 4.0 Generic Core Scales. Health Qual Life Outcomes 5(1):1-13
28. Varni JW, Limbers CA, Burwinkle TM (2007) Impaired healthrelated quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQLtm 4.0 Generic Core Scales. Health Qual Life Outcomes 5(43):1-15
29. Varni JW, Seid M, Knight TS, Burwinkle TM, Brown J, Szer IS (2002) The PedsQLtm in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventorytm Generic Core Scales and Rheumatology Module. Arthritis Rheum 46:714-725 (Pubitemid 34214252)
30. Varni JW, Seid M, Kurtin PS (2001) PedsQLtm 4.0: reliability and validity of the Pediatric Quality of Life Inventory™ version 4.0 Generic Core Scales in healthy and patient populations. Med Care 39:800-812 (Pubitemid 33686263)
31. Varni JW, Seid M, Rode CA (1999) The PedsQLtm: measurement model for the Pediatric Quality of Life Inventory.Med Care 37:126-139
32. World Health Organization (1948) Constitution of the World Health Organization: basic document. World Health Organization, Geneva